Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients

Condition:   Non-small Cell Lung Cancer
Interventions:   Drug: Nimotuzumab and TP regimen;   Drug: TP regimen
Sponsors:   Tianjin Medical University Cancer Institute and Hospital;   Biotech Pharmaceutical Co., Ltd.
Recruiting - verified February 2013

from #ORL via xlomafota13 on Inoreader http://ift.tt/1TqErWL
via IFTTT